These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20957015)

  • 1. [Preparation and in vitro evaluation of tanshinone IIA pulsatile release pellets].
    Liang XD; Zheng Y; Fan TY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 42(5):559-64. PubMed ID: 20957015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on preparation of isosorbide-5-mononitrate pulsatile controlled-release pellets and various influence factors].
    Wang R; Huang G; Fang Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):885-8. PubMed ID: 18788301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of drug release from pellets coated with HPMC or Surelease.
    Sadeghi F; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2000 Jun; 26(6):651-60. PubMed ID: 10826113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of drug release from pellets coated with Surelease containing hydroxypropylmethylcellulose.
    Sadeghi F; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2001 May; 27(5):419-30. PubMed ID: 11448049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation of Shuxiong pulsatile controlled-release dropping pill].
    Chen H; Chen YZ; Xie QC; Lin SY; Lin JC; Jianc WN
    Zhong Yao Cai; 2013 Jul; 36(7):1155-8. PubMed ID: 24417154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation of verapamil hydrochloride controlled-onset extended-release pellets and its pharmacokinetics in dogs].
    Chen ZP; Xiao YY; Chen HX; Chen XJ; Li LR; Zhu JB
    Yao Xue Xue Bao; 2006 Aug; 41(8):765-71. PubMed ID: 17039785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation.
    Yadav D; Survase S; Kumar N
    Int J Pharm; 2011 Oct; 419(1-2):121-30. PubMed ID: 21807081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel multi-unit tablet for treating circadian rhythm diseases.
    Liu Q; Gong Y; Shi Y; Jiang L; Zheng C; Ge L; Liu J; Zhu J
    AAPS PharmSciTech; 2013 Jun; 14(2):861-9. PubMed ID: 23649996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
    Lee BJ; Ryu SG; Cui JH
    Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compression of coated drug beads for sustained release tablet of glipizide: formulation, and dissolution.
    Nguyen C; Christensen JM; Ayres JW
    Pharm Dev Technol; 2014 Feb; 19(1):10-20. PubMed ID: 23259589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of Surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form.
    Kim MS; Jun SW; Lee S; Lee TW; Park JS; Hwang SJ
    J Pharm Pharmacol; 2005 Jun; 57(6):735-42. PubMed ID: 15969928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of pulsatile release tablets with swelling and rupturable layers.
    Sungthongjeen S; Puttipipatkhachorn S; Paeratakul O; Dashevsky A; Bodmeier R
    J Control Release; 2004 Mar; 95(2):147-59. PubMed ID: 14980764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of water soluble additives and HPMCP on drug release from Surelease-coated pellets containing tamsulosin hydrochloride.
    Kim MS; Kim JS; Kang SH; Yoo YH; Lee S; Park JS; Woo JS; Hwang SJ
    Arch Pharm Res; 2007 Aug; 30(8):1008-13. PubMed ID: 17879755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology.
    Kim MS; Kim JS; You YH; Park HJ; Lee S; Park JS; Woo JS; Hwang SJ
    Int J Pharm; 2007 Aug; 341(1-2):97-104. PubMed ID: 17499949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation and in vitro release characteristics of pulsed-release tablets of Apocynum venetum].
    Yang H; Xie F; Yang Y; Luo Y
    Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(11):1427-30. PubMed ID: 22779170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M; Newton M; Booth S; Clarke A
    Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of release of hydroxypropylmethyl cellulose on single and bilayer sustained-release matrix tablets].
    Yang YP; Wang MY; Chang JB; Guo MT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):291-6. PubMed ID: 23591354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.